Literature DB >> 23093674

Next-generation antibody discovery platforms.

Gary Hardiman1.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 23093674      PMCID： PMC3494954          DOI： 10.1073/pnas.1216406109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  10 in total

1.  Picomolar affinity antibodies from a fully synthetic naive library selected and evolved by ribosome display.

Authors:  J Hanes; C Schaffitzel; A Knappik; A Plückthun
Journal:  Nat Biotechnol       Date:  2000-12       Impact factor: 54.908

Review 2.  Protein microarrays: challenges and promises.

Authors:  Anupam Talapatra; Richard Rouse; Gary Hardiman
Journal:  Pharmacogenomics       Date:  2002-07       Impact factor: 2.533

Review 3.  Strategies and challenges for the next generation of therapeutic antibodies.

Authors:  Alain Beck; Thierry Wurch; Christian Bailly; Nathalie Corvaia
Journal:  Nat Rev Immunol       Date:  2010-05       Impact factor: 53.106

4.  Sequencing antibody repertoires: the next generation.

Authors:  Nicolas Fischer
Journal:  MAbs       Date:  2011-01-01       Impact factor: 5.857

Review 5.  Selecting and screening recombinant antibody libraries.

Authors:  Hennie R Hoogenboom
Journal:  Nat Biotechnol       Date:  2005-09       Impact factor: 54.908

6.  Modelling the human immune response: performance of a 1011 human antibody repertoire against a broad panel of therapeutically relevant antigens.

Authors:  C Lloyd; D Lowe; B Edwards; F Welsh; T Dilks; C Hardman; T Vaughan
Journal:  Protein Eng Des Sel       Date:  2008-10-29       Impact factor: 1.650

7.  Construction of a rationally designed antibody platform for sequencing-assisted selection.

Authors:  H Benjamin Larman; George Jing Xu; Natalya N Pavlova; Stephen J Elledge
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-11       Impact factor: 11.205

8.  By-passing in vitro screening--next generation sequencing technologies applied to antibody display and in silico candidate selection.

Authors:  U Ravn; F Gueneau; L Baerlocher; M Osteras; M Desmurs; P Malinge; G Magistrelli; L Farinelli; M H Kosco-Vilbois; N Fischer
Journal:  Nucleic Acids Res       Date:  2010-09-15       Impact factor: 16.971

9.  The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies.

Authors:  Christine Rothe; Stefanie Urlinger; Corinna Löhning; Josef Prassler; Yvonne Stark; Ute Jäger; Bernd Hubner; Michael Bardroff; Ingrid Pradel; Melanie Boss; Renate Bittlingmaier; Tschimegma Bataa; Christian Frisch; Bodo Brocks; Annemarie Honegger; Margit Urban
Journal:  J Mol Biol       Date:  2007-12-15       Impact factor: 5.469

10.  An analysis of the sequences of the variable regions of Bence Jones proteins and myeloma light chains and their implications for antibody complementarity.

Authors:  T T Wu; E A Kabat
Journal:  J Exp Med       Date:  1970-08-01       Impact factor: 14.307
  10 in total
  4 in total

Review 1.  Current status and recent advances of next generation sequencing techniques in immunological repertoire.

Authors:  X-L Hou; L Wang; Y-L Ding; Q Xie; H-Y Diao
Journal:  Genes Immun       Date:  2016-03-10       Impact factor: 2.676

2.  A polymer nanoparticle with engineered affinity for a vascular endothelial growth factor (VEGF165).

Authors:  Hiroyuki Koide; Keiichi Yoshimatsu; Yu Hoshino; Shih-Hui Lee; Ai Okajima; Saki Ariizumi; Yudai Narita; Yusuke Yonamine; Adam C Weisman; Yuri Nishimura; Naoto Oku; Yoshiko Miura; Kenneth J Shea
Journal:  Nat Chem       Date:  2017-03-27       Impact factor: 24.427

3.  Creation of recombinant antigen-binding molecules derived from hybridomas secreting specific antibodies.

Authors:  Conor Fields; David O'Connell; Sujing Xiao; Gil U Lee; Philippe Billiald; Julien Muzard
Journal:  Nat Protoc       Date:  2013-05-16       Impact factor: 13.491

4.  Clonal array profiling of scFv-displaying phages for high-throughput discovery of affinity-matured antibody mutants.

Authors:  Yuki Kiguchi; Hiroyuki Oyama; Izumi Morita; Mai Morikawa; Asuka Nakano; Wakana Fujihara; Yukari Inoue; Megumi Sasaki; Yuki Saijo; Yuki Kanemoto; Kaho Murayama; Yuki Baba; Atsuko Takeuchi; Norihiro Kobayashi
Journal:  Sci Rep       Date:  2020-08-24       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.